Le Lézard
Classified in: Health
Subject: TDS

Two Day Biocompatibility Testing for Medical Devices Seminar (San Francisco, CA, United States - November 8-9, 2018)


DUBLIN, Sept. 17, 2018 /PRNewswire/ --

The "Biocompatibility Testing for Medical Devices" conference has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The medical device field is one of the most heavily regulated industries, for obvious reasons. Medical devices are an important tool in efforts to improve patient care and treatment outcomes. Learn how to achieve more successful biocompatibility testing outcomes by attending this seminar.

Biocompatibility testing is in the spotlight with regulatory bodies - especially with the recent release of the updated European MDRs and the FDA's Guidance document on ISO 10993-1. It is essential for medical device manufacturers to have an understanding of the current landscape for biocompatibility testing while keeping an eye on the future trends that will affect future requirements. This seminar will discuss the recent changes to regulatory documents and standards and how they will impact the overall biocompatibility assessment of medical devices.

Attendees will understand and apply ISO 10993-1 and the FDA Guidance on its use. They will know how to use the ISO documents to locate information that you need. Understand what tests to select and how to choose among various options.

By attending this seminar, attendees will get answers of these questions:

Learning Objectives:

After completing this seminar, participants should be familiar with the full scope of ISO 10993-1, including the current version.

The topics covered will include:

Areas Covered:

The areas that will be discussed in the seminar will include the following topics throughout the agenda:

Who Should Attend:

For more information about this conference visit

https://www.researchandmarkets.com/research/b4sr8x/two_day?w=5

Media Contact:

Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 16:19
Unifor expects to achieve the wage increases and benefit improvements awarded to Ontario OCHU-CUPE and SEIU Healthcare members by Arbitrator William Kaplan in a recent decision....

at 16:10
Acadia Pharmaceuticals Inc. today announced that on April 10, 2024, the Compensation Committee of Acadia's Board of Directors (the "Committee") granted inducement awards consisting of non-qualified stock options to purchase 21,659 shares of common...

at 16:10
Calidi Biotherapeutics, Inc. , a clinical-stage biotechnology company developing a new generation of targeted immunotherapies, today announced the closing of its previously announced public offering of 15,197,500 shares of common stock (or pre-funded...

at 15:55
Valley Mountain Regional Center ("VMRC") experienced a data security incident that involved personal and / or protected health information belonging to certain current and former patients and has provided notice of this incident to impacted...

at 15:44
Late yesterday the United States District Court for the Northern California ruled that CVS acted intentionally under the "deliberate indifference" standard when it implemented a drug program that discriminates against people living with HIV....

at 15:33
Alameda Health System needs help identifying a patient who arrived at the Wilma Chan Highland Hospital Campus on March 15, 2024, without identification....



News published on and distributed by: